Celgenyx Gene Technology

Company Deals

Celgenyx Completes RMB 100M Series A Financing for Next-Gen Cell Therapy Development

Fineline Cube Oct 25, 2022

China-based Hangzhou Celgenyx Gene Technology Co., Ltd has announced the completion of a Series A...

Company Drug

Hengrui’s Rezvilutamide Receives EMA Acceptance for Metastatic Prostate Cancer Treatment

Company Deals

AbbVie to Acquire Apogee Therapeutics for $10.9B to Expand Inflammatory Disease Pipeline

Company Deals

BioArctic Partners with Eli Lilly on Novel Neurodegenerative Disease Therapy Using BrainTransporter Platform

Company Drug

CARsgen Therapeutics Secures World’s First Solid Tumor CAR-T Approval with Kylimei for Gastric Cancer